Impact of Obesity on Operative Time in Pediatric Adenotonsillectomy

Dhivyaa Anandan1, Daniel R S Habib1, Amy S Whigham1,2

  • 1Surgical Outcomes Center for Kids, Vanderbilt University Medical Center, Nashville, TN, USA.

Insights

Pediatric adenotonsillectomy (AT) operative times are longer in obese children. This finding impacts surgical scheduling and patient counseling for children undergoing AT.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Anesthesiology

Background:

  • Obesity is a growing concern in pediatric populations.
  • Limited research exists on the impact of obesity on pediatric adenotonsillectomy (AT) operative times.

Purpose of the Study:

  • To compare operative times for pediatric adenotonsillectomy (AT) in patients with and without obesity.
  • To identify specific time components (induction, operative, emergence, total OR time) affected by obesity.

Main Methods:

  • Retrospective analysis of 499 pediatric patients (ages 3-17) who underwent AT.
  • Data collected included induction time, operative time, emergence time, and total operating room (OR) time.
  • Statistical analysis included t-tests, Pearson's tests, and multivariable linear regressions.

Main Results:

  • Obese patients had significantly longer induction times, operative times, emergence times, and total OR times compared to non-obese patients.
  • Multivariable regression confirmed obesity as a significant predictor of increased time in all measured OR components.
  • Obese patients were more likely to be older and have asthma or reactive airway disease.

Conclusions:

  • Obesity is independently associated with increased operative times for pediatric adenotonsillectomy (AT).
  • These findings necessitate adjustments in surgical scheduling and perioperative counseling for obese pediatric patients.
  • Further research may explore specific anesthetic or surgical techniques to mitigate these time increases.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...